The current effective delivered dose is a quality indicator for continuous renal replacement therapy. Its periodic assessment might enable physicians to deliver personalised treatments. Yet, its quantification as by extracorporeal urea clearance (Cl) is cumbersome and thus often neglected in routine practice. The aim of this in vitro study is to demonstrate the non-inferior effectiveness of assessing the current effective delivered dose using a simpler, cheaper and faster approach based on measurement of fluoride rather than urea extracorporeal Cl.
Use of Fluoride as a Marker Solute to Quantify the Current Effective Delivered Dose in Continuous Renal Replacement Therapy: An "in vitro" Study / Villa, Gianluca; Bocciero, Vittorio; Neri, Mauro; Pomarè Montin, Diego; Angeli, Elena; Di Filippo, Alessandro; Falsini, Silvia; Adembri, Chiara; De Gaudio, Angelo Raffaele; Romagnoli, Stefano. - In: BLOOD PURIFICATION. - ISSN 0253-5068. - ELETTRONICO. - (2020), pp. 1-7. [10.1159/000507013]
Use of Fluoride as a Marker Solute to Quantify the Current Effective Delivered Dose in Continuous Renal Replacement Therapy: An "in vitro" Study
Villa, Gianluca
;Bocciero, Vittorio;Pomarè Montin, Diego;Angeli, Elena;Di Filippo, Alessandro;Falsini, Silvia;Adembri, Chiara;De Gaudio, Angelo Raffaele;Romagnoli, Stefano
2020
Abstract
The current effective delivered dose is a quality indicator for continuous renal replacement therapy. Its periodic assessment might enable physicians to deliver personalised treatments. Yet, its quantification as by extracorporeal urea clearance (Cl) is cumbersome and thus often neglected in routine practice. The aim of this in vitro study is to demonstrate the non-inferior effectiveness of assessing the current effective delivered dose using a simpler, cheaper and faster approach based on measurement of fluoride rather than urea extracorporeal Cl.I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.